142 related articles for article (PubMed ID: 16436165)
1. Talking about tamoxifen.
Goodare H
Health Expect; 2006 Mar; 9(1):91. PubMed ID: 16436165
[No Abstract] [Full Text] [Related]
2. Involvement of the consumer voice.
Thornton H; Baum M; Clarke M
Health Expect; 2006 Mar; 9(1):92-3; author reply 93. PubMed ID: 16436166
[No Abstract] [Full Text] [Related]
3. Exemestane or tamoxifen?
Ueda M; Toji E; Noda S
Lancet; 2007 May; 369(9573):1600; author reply 1600-1. PubMed ID: 17499595
[No Abstract] [Full Text] [Related]
4. Bilateral swollen eyelids occurring during adjuvant treatment with tamoxifen for early breast cancer.
Jaspers H; Blaisse R; Maessen-Visch B; Mattijssen V
Neth J Med; 2009 Jun; 67(6):245-6. PubMed ID: 19749398
[No Abstract] [Full Text] [Related]
5. Tamoxifen in early breast cancer.
Saibara T; Ogawa Y; Onishi S
Lancet; 1998 Aug; 352(9125):404. PubMed ID: 9717954
[No Abstract] [Full Text] [Related]
6. Tamoxifen for breast cancer.
Karn A; Jha AK; Shrestha S; Acharya B; Poudel S; Bhandari RB
JNMA J Nepal Med Assoc; 2010; 49(177):62-7. PubMed ID: 21180225
[TBL] [Abstract][Full Text] [Related]
7. Endoxifen shows promise in breast cancer.
Cancer Discov; 2014 Feb; 4(2):OF1. PubMed ID: 24501306
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen chemoprevention and cardiac disease.
Narod SA; Iqbal J
J Clin Oncol; 2011 Aug; 29(22):3106-7; author reply 3107. PubMed ID: 21709203
[No Abstract] [Full Text] [Related]
9. Tamoxifen and risk of endometrial cancer.
Marsh F; Mayfield M
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
[No Abstract] [Full Text] [Related]
10. Tamoxifen and risk of endometrial cancer.
Kairies P
Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
[No Abstract] [Full Text] [Related]
11. Tamoxifen and risk of endometrial cancer.
Lasset C; Bonadona V; Mignotte H; Brémond A
Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
[No Abstract] [Full Text] [Related]
12. Tamoxifen and risk of endometrial cancer.
Atkins CD
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
[No Abstract] [Full Text] [Related]
13. Tamoxifen and risk of endometrial cancer.
Tempfer C; Kubista E
Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
[No Abstract] [Full Text] [Related]
14. Tamoxifen and risk of endometrial cancer.
Narod SA; Pal T; Graham T; Mitchell M; Fyles A
Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
[No Abstract] [Full Text] [Related]
15. [Tamoxifen; wider indications, more frequent controls?].
Rutgers EJ; Nortier JW; Beex I;
Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1766-7. PubMed ID: 11589197
[No Abstract] [Full Text] [Related]
16. Tamoxifen-induced radiation recall dermatitis.
Kundranda MN; Daw HA
Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
[No Abstract] [Full Text] [Related]
17. Uterine carcinosarcoma related to tamoxifen.
McCluggage WG
Int J Gynecol Cancer; 2003; 13(5):697-8; author reply 697-8. PubMed ID: 14675359
[No Abstract] [Full Text] [Related]
18. Tamoxifen-induced hepatotoxicity.
Ahbeddou N; Belbaraka R; Fetohi M; Errihani H
Indian J Cancer; 2011; 48(3):385. PubMed ID: 21921356
[No Abstract] [Full Text] [Related]
19. Screening recommendation for women taking tamoxifen.
Kawabata H; Ueno T
Lancet; 2001 Sep; 358(9286):1018. PubMed ID: 11593503
[No Abstract] [Full Text] [Related]
20. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
McCaul KA
Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
